CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil

INTRODUCTION: Chimeric antigen receptor T (CAR-T) cell therapy is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) that is a multi-step process involving various stakeholders. Appropriate education on the practical logistics is therefore paramount to ensure treatment succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hungria, Vania, Piérola, Ana Alfonso, Filho, Jayr Schmidt, Crusoe, Edvan, Filho, Roberto José Pessoa de Magalhães, Maiolino, Angelo, Rodríguez-Otero, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244253/
https://www.ncbi.nlm.nih.gov/pubmed/36243623
http://dx.doi.org/10.1016/j.htct.2022.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244253/
https://www.ncbi.nlm.nih.gov/pubmed/36243623
http://dx.doi.org/10.1016/j.htct.2022.08.002

Ejemplares similares